Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Betamethasone

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44339   clinical trials with a EudraCT protocol, of which   7369   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    109 result(s) found for: Betamethasone. Displaying page 3 of 6.
    « Previous 1  2  3  4  5  6  Next»
    EudraCT Number: 2010-018355-10 Sponsor Protocol Number: H553000-1001 Start Date*: 2010-06-18
    Sponsor Name:Almirall Hermal GmbH
    Full Title: An Investigator-blind, Controlled Study to Assess the Efficacy of Five Distinct Combinations of LAS 41004 in Different Concentrations Compared to Placebo and to Two Active Controls in a Psoriasis-P...
    Medical condition: Plaque-type psoriasis (psoriasis vulgaris) for at least 6 months
    Disease: Version SOC Term Classification Code Term Level
    12.1 10050576 Psoriasis vulgaris LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2011-001384-45 Sponsor Protocol Number: H553000-1101 Start Date*: 2011-06-29
    Sponsor Name:Almirall Hermal GmbH
    Full Title: A 22 day bland ointment and reference-controlled, investigator-blind, single center, randomized, proof of concept clinical study with an intraindividual comparison investigating the anti-psoriatic ...
    Medical condition: Psoriasis vulgaris
    Disease: Version SOC Term Classification Code Term Level
    13.1 10040785 - Skin and subcutaneous tissue disorders 10050576 Psoriasis vulgaris LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2004-002861-19 Sponsor Protocol Number: MBL 0407 INT Start Date*: 2005-01-24
    Sponsor Name:LEO Pharma A/S
    Full Title: Long-term treatment of Scalp Psoriasis with Calciptriol plus Betamethasone dipropionate gel. A phase III safety study of a new gel containing calcipotriol 50mcg/g plus betamethasone 0.5 mg/g (as di...
    Medical condition: Psoriasis of the scalp Extent: Minimum 10% of the total scalp area Disease severity: Graded as "moderate", "severe", or "very severe" according to the investigator's global assessment of disease se...
    Disease: Version SOC Term Classification Code Term Level
    7.0 10037115 LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Completed) GB (Completed) DE (Completed)
    Trial results: View results
    EudraCT Number: 2016-003603-61 Sponsor Protocol Number: 002 Start Date*: 2017-07-19
    Sponsor Name:
    Full Title: Clinical trial on the administration of 3 doses of betamethasone (12 mg) in 18 hours apart in twin pregnancy patients with threatened preterm birth treated by Atosiban, rather than 2 doses of betam...
    Medical condition: Premature delivery in twin pregnancies
    Disease: Version SOC Term Classification Code Term Level
    19.1 100000004868 10028244 Multiple pregnancy affecting fetus or newborn LLT
    19.1 100000004868 10036564 Pregnancy multiple LLT
    Population Age: Adults Gender: Female
    Trial protocol: BE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2005-005792-15 Sponsor Protocol Number: 250816BS Start Date*: 2006-04-24
    Sponsor Name:Astion Danmark A/S
    Full Title: Evaluation of the efficacy of topical formulations containing ASF-1075 in the prevention and treatment of contact dermatitis
    Medical condition: Male or female volunteers with known nickel allergy and with healthy skin in the test area, aged 18 years or older
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2015-001146-29 Sponsor Protocol Number: 1 Start Date*: 2016-01-12
    Sponsor Name:Hospital Central de la Defensa
    Full Title: Selective local anesthesia versus a combined medication injection with corticosteroids in degenerartive spine
    Medical condition: Degenerative spine pain when there are no indications for surgical treatment
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: (No results available)
    EudraCT Number: 2006-006487-32 Sponsor Protocol Number: RD.03.SPR. 40041 Start Date*: 2007-02-27
    Sponsor Name:GALDERMA R&D SNC
    Full Title: CLINICAL EFFICACY EVALUATION OF A FIXED COMBINATION OF CALCITRIOL 3 µg/g WITH THREE CONCENTRATIONS (100, 250, 500µg/g) OF CLOBETASOL PROPIONATE AS SPRAY FORMULATION USING THE MODIFIED DUMAS-SCHOLTZ...
    Medical condition: Treatment of psoriasis vulgaris
    Disease: Version SOC Term Classification Code Term Level
    9.1 10050576 Psoriasis vulgaris LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Completed)
    Trial results: View results
    EudraCT Number: 2007-005463-10 Sponsor Protocol Number: PLQ-001 Start Date*: 2008-02-06
    Sponsor Name:LEO Pharma A/S
    Full Title: A plaque test comparing three marketed products and two products in development and a vehicle control for the treatment of psoriasis vulgaris
    Medical condition: Psoriasis vulgaris lesions located on the arms, legs or trunk.
    Disease: Version SOC Term Classification Code Term Level
    9.1 10050576 Psoriasis vulgaris LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Completed)
    Trial results: View results
    EudraCT Number: 2008-005487-13 Sponsor Protocol Number: PLQ-002 Start Date*: 2008-12-30
    Sponsor Name:LEO Pharma A/S
    Full Title: A plaque test comparing 4 steroids with Daivobet® ointment and a vehicle control for the treatment of psoriasis vulgaris
    Medical condition: Psoriasis vulgaris lesions located on the arms, legs or trunk.
    Disease: Version SOC Term Classification Code Term Level
    9.1 10050576 Psoriasis vulgaris LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Completed)
    Trial results: View results
    EudraCT Number: 2016-000556-95 Sponsor Protocol Number: LP0053-1004 Start Date*: 2017-01-03
    Sponsor Name:LEO Pharma A/S
    Full Title: LEO 90100 twice weekly maintenance regimen for psoriasis vulgaris
    Medical condition: Psoriasis vulgaris
    Disease: Version SOC Term Classification Code Term Level
    19.1 100000004858 10050576 Psoriasis vulgaris LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed) FR (Completed) PL (Completed)
    Trial results: View results
    EudraCT Number: 2018-000685-12 Sponsor Protocol Number: MC2-01-C6 Start Date*: Information not available in EudraCT
    Sponsor Name:MC2 Therapeutics Ltd
    Full Title: A Multicentre, Open-label, Single-group Maximal Use Trial, Evaluating the Safety and Pharmacokinetic Profile of the Active Ingredients and their Metabolites after application of MC2-01 Cream in Ado...
    Medical condition: Extensive Psoriasis Vulgaris
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004858 10050576 Psoriasis vulgaris LLT
    Population Age: Adolescents, Under 18 Gender: Male, Female
    Trial protocol: DE (Prematurely Ended) CZ (Completed) HU (Completed)
    Trial results: View results
    EudraCT Number: 2006-003327-36 Sponsor Protocol Number: ART1 Start Date*: 2007-01-08
    Sponsor Name:Guy's & St Thomas' NHS Foundation Trust [...]
    1. Guy's & St Thomas' NHS Foundation Trust
    2. King's College London
    Full Title: Evaluation of the efficacy of colchicine with and without betamethasone mouthwash in the management of recurrent aphthous stomatitis
    Medical condition: Recurrent aphthous stomatitis (RAS)
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2006-001186-42 Sponsor Protocol Number: 260114BS, ASF 1075-203 Start Date*: 2006-07-21
    Sponsor Name:Astion Danmark A/S
    Full Title: Determination of antipsoriatic efficacy of topical formulations in a psoriasis plaque test
    Medical condition: male or female subjects with chronic plaque type psoriasis
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2018-001305-82 Sponsor Protocol Number: IC3627/18 Start Date*: 2019-05-16
    Sponsor Name:Laura Perelló Moreno
    Full Title: Study on the advantages of local post-operative infiltration in forefoot surgery.
    Medical condition: management of postoperative pain in ambulatory foot surgery that allows the realization of immediate rehabilitation and better functional results and personal satisfaction
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2017-004833-10 Sponsor Protocol Number: EC12/2017 Start Date*: 2018-01-15
    Sponsor Name:Fundación para la Investigación Biomédica
    Full Title: Clinical trial ramdomized for treatment of perineal pain and dyspareunia portpartum through local anesthetic infiltrations vs anesthetic and corticoids
    Medical condition: perineal pain and dyspareunia postpartum
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2005-003050-96 Sponsor Protocol Number: 04EU/BMT06 Start Date*: 2005-12-02
    Sponsor Name:IBSA
    Full Title: Multicentre, prospective, assessor-blind, in parallel groups randomised and vs reference marketed product controlled confirmatory trial of the efficacy and safety of IBSA BMV medicated plaster for ...
    Medical condition: chronic plaque psoriasis
    Disease: Version SOC Term Classification Code Term Level
    9.1 10033898 Parapsoriasis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: View results
    EudraCT Number: 2018-001970-66 Sponsor Protocol Number: MC2-01-C7 Start Date*: 2018-12-05
    Sponsor Name:MC2 Therapeutics Ltd.
    Full Title: A Randomised, Multicentre, Investigator-Blind, Parallel-Group Trial to Evaluate the Efficacy and Safety of MC2-01 Cream Compared to Vehicle and Active Comparator in Subjects with Mild-to-Moderate P...
    Medical condition: mild-to-moderate psoriasis vulgaris
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004858 10050576 Psoriasis vulgaris LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: CZ (Completed)
    Trial results: View results
    EudraCT Number: 2013-000873-56 Sponsor Protocol Number: CARPA2013 Start Date*: 2013-07-04
    Sponsor Name:Federico Diaz González
    Full Title: Randomized, two paralel groups, open clinical trial stratified by severity to stimate the cost-effectivity of surgical vs corticosteroid injection treatment on carpal tunnel syndrome
    Medical condition: Carpal tunnel syndrome
    Disease: Version SOC Term Classification Code Term Level
    14.1 10029205 - Nervous system disorders 10007697 Carpal tunnel syndrome PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2004-004824-11 Sponsor Protocol Number: ELBE-2005 Start Date*: 2005-04-15
    Sponsor Name:Universitätshautklinik Kiel
    Full Title: Role for pimecrolimus in restoring skin barrier function and normalizing epidermal lipid content and differentiation in atopic epidermis: a randomized, intra-patient, double-blind (right/left arm) ...
    Medical condition: Atopic Dermatitis
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2010-022281-27 Sponsor Protocol Number: H553000-1005 Start Date*: 2010-12-20
    Sponsor Name:Almirall Hermal GmbH
    Full Title: An Investigator-blind, Controlled Study to Assess the Efficacy and Safety of different formulations of LAS 41004 Compared to Placebo and to Active Control in a Psoriasis-Plaque-Test
    Medical condition: Plaque-type psoriasis (psoriasis vulgaris) for at least 6 months
    Disease: Version SOC Term Classification Code Term Level
    12.1 10050576 Psoriasis vulgaris LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    « Previous 1  2  3  4  5  6  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Sun Jun 01 19:38:58 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA